CH
RPRX icon

Cromwell Holdings’s Royalty Pharma RPRX Stock Holding History

Cromwell Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.57K Buy
135
+69
+105% +$3.59K ﹤0.01% 628
2026
Q1 		$3.17K Hold
66
– – ﹤0.01% 643
2025
Q4 		$2.55K Hold
66
– – ﹤0.01% 660
2025
Q3 		$2.33K Hold
66
– – ﹤0.01% 681
2025
Q2 		$2.38K Buy
66
+42
+175% +$1.39K ﹤0.01% 661
2025
Q1 		$747 Buy
+24
New +$761 ﹤0.01% 698

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cromwell Holdings's RPRX Position: Q2 2026 in Review

Cromwell Holdings increased its Royalty Pharma (RPRX) stake by 105% in Q2 2026, buying an estimated $3.59K and bringing the position to 135 shares worth $7.57K. The position accounts for ﹤0.01% of the portfolio, ranked #628.

Cromwell Holdings first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Cromwell Holdings held 135 shares of Royalty Pharma worth $7.57K as of Q2 2026.
  • Cromwell Holdings bought 69 Royalty Pharma shares in Q2 2026, an estimated $3.59K.
  • Royalty Pharma made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #628 holding.
  • Cromwell Holdings first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.